Pharmaceutical Industries Stock Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceutical industries stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceutical Industries Stock Down Today - Breaking & Trending Today

Keystone Financial Group Reduces Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Keystone Financial Group trimmed its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 46,354 shares of the company’s stock after selling 900 shares during the quarter. Keystone […] ....

Los Angeles , United States , New Zealand General , New Zealand , Vikkil Conway , Amir Weiss , Piper Sandler , Goldman Sachs Group , Los Angeles Capital Management , Wellington Management Group , Quarter For Teva Pharmaceutical Industries , Sg Americas Securities , Gateway Investment Advisers , Teva Pharmaceutical Industries Profile , Jpmorgan Chase Co , News Ratings For Teva Pharmaceutical Industries Daily , Teva Pharmaceutical Industries , Teva Pharmaceutical Industries Stock Down , Jefferies Financial Group , Teva Pharmaceutical Industries Limited , Keystone Financial Group , Free Report , Financial Group , Angeles Capital Management , Management Group , Investment Advisers ,

Teva Pharmaceutical Industries Limited Expected to Post Q3 2025 Earnings of $0.62 Per Share (NYSE:TEVA)

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research raised their Q3 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research report issued to clients and investors on Wednesday, May 1st. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of […] ....

New Zealand General , New Zealand , Los Angeles , United States , Mark Sabag , Piper Sandler , Gateway Investment Advisers , Analysts At Zacks Research , News Ratings For Teva Pharmaceutical Industries Daily , Zacks Research , Hr Department , Goldman Sachs Group , Jpmorgan Chase Co , Jefferies Financial Group , Insider Transactions At Teva Pharmaceutical Industries , Securities Exchange Commission , Teva Pharmaceutical Industries Stock Down , Los Angeles Capital Management , Teva Pharmaceutical Industries Company Profile , Teva Pharmaceutical Industries Limited , Sg Americas Securities , Teva Pharmaceutical Industries , Wellington Management Group , Free Report , Teva Pharmaceutical Industrie , Financial Group ,

Taro Pharmaceutical Industries (NYSE:TARO) Share Price Passes Above Two Hundred Day Moving Average of $40.01

Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $40.01 and traded as high as $42.49. Taro Pharmaceutical Industries shares last traded at $42.40, with a volume of 27,051 shares. Analyst Upgrades and Downgrades A number […] ....

United States , Taro Pharmaceutical Industries Ltd , Taro Pharmaceutical Industries , York Mellon Corp , Taro Pharmaceutical Industries Stock Down , Harvest Management , Allspring Global Investments Holdings , Sg Americas Securities , News Ratings For Taro Pharmaceutical Industries Daily , Get Free Report , Pharmaceutical Industries , Pharmaceutical Industries Stock Down , New York Mellon Corp , Pharmaceutical Industries Ltd , Taro Pharmaceutical Industries Daily , Nyse Taro ,

Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research report released on Sunday morning. The firm issued a strong-buy rating on the stock. Separately, HC Wainwright cut Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 target price on the stock. in […] ....

United States , Mitsubishi Ufj , Us Bancorp , American Century Companies Inc , Taro Pharmaceutical Industries , News Ratings For Taro Pharmaceutical Industries Daily , Dimensional Fund Advisors , Banking Corp , Taro Pharmaceutical Industries Stock Down , Taro Pharmaceutical Industries Ltd , Swiss National Bank , Taro Pharmaceutical Industries Company Profile , Free Report , Pharmaceutical Industries Stock Down , Pharmaceutical Industries , Get Free Report , National Bank , Century Companies , Fund Advisors , Pharmaceutical Industries Ltd , Taro Pharmaceutical Industries Daily , Nyse Taro , Initiated Coverage , Stocknews Com ,

StockNews.com Initiates Coverage on Taro Pharmaceutical Industries (NYSE:TARO)

StockNews.com began coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a research note released on Thursday morning. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright cut shares of Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price objective on the […] ....

United States , Us Bancorp , Taro Pharmaceutical Industries Company Profile , Taro Pharmaceutical Industries Ltd , Swiss National Bank , American Century Companies Inc , Banking Corp , Dimensional Fund Advisors , Taro Pharmaceutical Industries , News Ratings For Taro Pharmaceutical Industries Daily , Mitsubishi Ufj , Taro Pharmaceutical Industries Stock Down , Free Report , Pharmaceutical Industries Stock Down , Pharmaceutical Industries , Get Free Report , National Bank , Century Companies , Fund Advisors , Pharmaceutical Industries Ltd , Taro Pharmaceutical Industries Daily , Nyse Taro , Initiated Coverage , Stocknews Com ,